Kapil Mishra, MD, discusses his presentation title "Radiation Retinopathy: Future Strategies" given at the 2025 Retina World ...

Earlier this year, Cullinan said its lead candidate hit the bull's-eye in a midstage lung cancer cancer trial but stayed mum ...

Data to be presented at ASCO reflect Boehringer's broad pipeline and growing body of evidence supporting innovative therapies for various cancersPatient-reported outcomes from the Beamion LUNG-1 study ...

Bristol-Myers Squibb (NYSE:BMY) is advancing in oncology, as evidenced by its upcoming presentations at the 2025 ASCO Annual ...

Dr Louisa Dlamini from Mabopane makes history as the University of Pretoria’s first black graduate with an MMed in Radiation ...

Genmab has shared the first data on rinatabart sesutecan (Rina-S) in advanced endome | Genmab has shared the first data on ...

Melphalan/hepatic delivery system showed better survival and response rates than best alternative care in metastatic uveal ...

Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), today announced that company management will participate in the Jefferies ...

Assistance from artificial intelligence can potenially increase the number of patients eligible for treatment for HER2-low ...

DPOAE testing showed no hearing loss in children with retinoblastoma treated with intra-arterial paraplatin, suggesting ...

Six doctors who specialize in prostate cancer discuss what President Biden's recent diagnosis does and doesn't mean for his ...

GSK’s Blenrep combinations receives Japanese approval for treatment of relapsed/refractory multiple myeloma: London, UK Tuesday, May 20, 2025, 12:00 Hrs [IST] GSK plc announced ...